SPA Directory Part 3: L-R

Here is the 3rd portion of the SPA Directory for companies L-R.  As always I welcome your comments on any SPA agreements that are not shown here, especially active ongoing studies.

LCI	Lannett	C-Topical	Local anesthesia	http://www.streetinsider.com/Corporate+News/Lannett+(LCI),+FDA+Reach+Agreement+Over+SPA+for+C-Topical+Phase+III/7054155.html	YES	n/a	n/a
nil	Lantheus	Flurpiridaz F18	Myocardial perfusion imaging	http://www.lantheus.com/News-Press-2011-0311.html	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01347710?term=Flurpiridaz+F18&rank=1	Dec-12
CSE:VELO	LifeCycle Pharma	LCP-Tacro	Kidney Transplant	http://www.news-medical.net/news/20100812/FDA-grants-LifeCycle-Pharma-SPA-for-LCP-Tacro-pivotal-Phase-3-study-in-de-novo-kidney-transplant-patients.aspx	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01187953?term=LCP-tacro&rank=8	Mar-13
nil	Macrocure	CureXcell	Chronic diabetic ulcers	https://sos.cision.com/node/499686	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01421966?term=macrocure&rank=3	Feb-15
TSE:4508	Mitsubishi Tanabe Pharma Co	Collategene	Advanced PAD	http://www.anges-mg.com/en/news/pdf/20121024.pdf	Yes	n/a	n/a
nil	Nanotherapeutics	Ramoplanin	C Diff	http://www.nanotherapeutics.com/products_pipeline_ramoplanin.php	Yes	n/a	n/a
NLNK	New Link Genetics	HyperAcute immunotherapy	Pancreatic cancer	http://www.linkp.com/products/hyperacute-pancreas.html	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01072981?term=hyperacute+pancreas&rank=1	Jan-14
nil	NovaRx	Lucanix	Advanced NSCLC	http://www.prnewswire.com/news-releases/novarx-completes-enrollment-in-lucanix-pivitol-phase-iii-therapeutic-vaccine-trial-for-post-frontline-maintenace-therapy-in-non-small-cell-lung-cancer-159688685.html	Yes	http://www.clinicaltrials.gov/ct2/show/NCT00676507?term=NovaRx&rank=2	Oct-12
OXGI	Oncogenix	Custirsen	Cancer pain in mCRPC	http://oncogenex.com/physicians/custirsen-ogx-011	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01188187?term=Custirsen&rank=6	Dec-13
nil	Onconova	Estybon	Myelodysplastic Syndromes	http://www.eurekalert.org/pub_releases/2010-10/poc-oaf100410.php	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01241500?term=onconova&rank=13	Oct-13	Interim analysis
ONXX	Onyx Pharma	Carfilzomib	2L MM +lenolidomide	http://www.onyx.com/view.cfm/626/onyx-pharmaceuticals-receives-fda-accelerated-approval-of-kyprolis-carfilzomib-for-injection-	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01568866?term=carfilzomib&phase=2&rank=1	Jan-15
OREX	Orexigen	Contrave	Obesity	http://ir.orexigen.com/phoenix.zhtml?c=207034&p=irol-newsArticle&id=1656731	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01601704?term=orexigen&rank=1	Sep-13
OXGN	Oxigene	Zybrestat	Anaplastic Thyroid Cancer	http://investor.oxigene.com/releasedetail.cfm?ReleaseID=707372	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01701349?term=oxigene&rank=5	Dec-16
nil	Paratek	Omadacycline	ABSSSI	http://www.paratekpharm.com/press/032812_SPA_ECCMID_release.pdf	Yes	n/a	n/a
nil	Paratek	Omadacycline	CABP	http://www.paratekpharm.com/press/032812_SPA_ECCMID_release.pdf	Yes	n/a	n/a
n/a	Pervasis	Vascugel	Fistula/Graft failure prevention	http://www.prnewswire.com/news-releases/pervasis-receives-fda-fast-track-status-for-vascugel-to-prevent-arteriovenous-access-failure-in-patients-undergoing-hemodialysis-115553949.html	Yes	n/a	n/a
PXSL	Pharmaxis	Bronchitol	Bronchiectasis	http://www.prnewswire.com/news-releases/pharmaxis-concludes-special-protocol-assessment-with-fda-for-bronchitol-phase-3-trial-57511597.html	Yes	http://www.clinicaltrials.gov/ct2/show/NCT00669331?term=pharmaxis&phase=2&rank=4	Jun-13
nil	Polaris Group	ADI-PEG 20	Advanced HCC	http://www.prnewswire.com/news-releases/fda-approves-special-protocol-assessment-for-phase-3-trial-of-polaris-groups-cancer-therapeutic-adi-peg-20-in-the-treatment-of-hepatocellular-carcinoma-118979494.html	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01287585?term=Polaris+group&rank=1&submit_fld_opt=	Jun-13
PVCT	Provectus	Rose Bengal	Melanoma	http://www.pvct.com/pressrelease.html?article=20121002	pending	n/a	n/a
RPTP	Raptor	DR Cysteamine	Nephropathic Cystinosis	http://ir.raptorpharma.com/releasedetail.cfm?releaseid=633905	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01000961?term=raptor&rank=11	Jun-11
RPRX	Repros	Androxal	Hypogonadism	http://www.reprosrx.com/pr_20120912_repros_updates_androxal_phase_3.php	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01534208?term=REPROS&rank=30	Jul-13